COPPOLA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 1.878
AS - Asia 1.864
EU - Europa 1.129
SA - Sud America 204
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 45
OC - Oceania 3
Totale 5.256
Nazione #
US - Stati Uniti d'America 1.804
SG - Singapore 896
RU - Federazione Russa 624
CN - Cina 367
VN - Vietnam 303
BR - Brasile 157
HK - Hong Kong 135
IT - Italia 81
DE - Germania 72
NL - Olanda 65
FR - Francia 61
FI - Finlandia 60
IE - Irlanda 43
GB - Regno Unito 38
CA - Canada 34
JP - Giappone 34
UA - Ucraina 32
IN - India 25
MX - Messico 24
AR - Argentina 18
BD - Bangladesh 18
CI - Costa d'Avorio 15
IQ - Iraq 15
KR - Corea 15
SE - Svezia 15
ZA - Sudafrica 14
PL - Polonia 12
PH - Filippine 9
CO - Colombia 8
ES - Italia 6
PY - Paraguay 6
VE - Venezuela 6
JO - Giordania 5
PK - Pakistan 5
TH - Thailandia 5
TW - Taiwan 5
BE - Belgio 4
EC - Ecuador 4
KE - Kenya 4
TR - Turchia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
EG - Egitto 3
HR - Croazia 3
JM - Giamaica 3
RS - Serbia 3
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
ID - Indonesia 2
NC - Nuova Caledonia 2
NI - Nicaragua 2
NP - Nepal 2
PS - Palestinian Territory 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
FJ - Figi 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MQ - Martinica 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SD - Sudan 1
SN - Senegal 1
SV - El Salvador 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 5.126
Città #
Singapore 422
San Jose 336
Moscow 148
Beijing 133
Santa Clara 133
Ashburn 127
Hong Kong 125
Chandler 108
Council Bluffs 84
Ho Chi Minh City 82
Hefei 70
Hanoi 66
The Dalles 66
Amsterdam 60
Los Angeles 48
Lauterbourg 41
Boston 38
Princeton 37
Millbury 34
Munich 30
Nanjing 27
Tokyo 24
São Paulo 22
New York 21
Naples 20
Buffalo 19
Da Nang 19
Dallas 19
Mykolayiv 16
Jacksonville 15
Redondo Beach 15
Des Moines 13
Helsinki 13
Ottawa 13
Turku 13
Chennai 12
Seoul 12
Mexico City 11
Phoenix 11
Warsaw 11
Ann Arbor 10
Brooklyn 10
Wilmington 10
Woodbridge 10
Atlanta 9
Chicago 9
Haiphong 9
Falkenstein 8
Johannesburg 8
Napoli 8
Nuremberg 8
Baghdad 7
Charlotte 7
Frankfurt am Main 7
Montreal 7
Nanchang 7
Orem 7
Seattle 7
Boardman 6
Brasília 6
Hải Dương 6
Changsha 5
Curitiba 5
Dearborn 5
Denver 5
Jiaxing 5
London 5
Manchester 5
Miami 5
San Francisco 5
Shenyang 5
Amman 4
Asunción 4
Biên Hòa 4
Brussels 4
Buenos Aires 4
Joinville 4
Lawrence 4
Nairobi 4
New Delhi 4
Ninh Bình 4
Poplar 4
Queens 4
Stockholm 4
Tashkent 4
Ankara 3
Bắc Ninh 3
Caracas 3
Charleston 3
Formosa 3
Hebei 3
Houston 3
Jackson 3
Kingston 3
Kronberg 3
Kunming 3
Las Vegas 3
Medellín 3
Montoro Inferiore 3
Phủ Lý 3
Totale 2.831
Nome #
Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management. 149
The effect of hydrothermal treatment on attrition during the fluidized bed combustion of paper sludge 143
Inferior Vena Cava Agenesis and Deep Vein Thrombosis in the Young: A Review of the Literature and Local Experience 140
Bilateral adrenal hemorrhage in a noenate 138
Aberrant F8 gene intron 1 inversion with concomitant duplication and deletion in a severe hemophilia A patient from Southern Italy. 137
Diabetes,vascular complications and antiplatelet therapy: open problems 133
Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis 133
Attrition of limestone during CO2 capture in a fluidized bed calcium looping process 132
Acute adrenal insufficiency in a neonate with bilateral adrenal hemorrhage and combined prothrombotic risk factors. 132
The challenge of diagnosing pulmonary embolism in children, pregnant women, and elderly patients: a descriptive review of the literature. 131
Successful and safe long-term standard antiviral therapy in a patient with “Explosive” immune response in course of HCV-related liver cirrhosis 130
Can serum TGF-beta 1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis? 129
The infectious burden in atherothrombosis. 129
Calcium looping for post-combustion CO2 capture – Effect of water vapour 126
Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: The POTTER study 123
Cytomegalovirus-Associated Splanchnic Vein Thrombosis in Immunocompetent Patients: Two Case Reports and Literature Review 122
The effect of SO2 on fluidized bed calcium looping for CO2 capture 122
Predisposing factors in patients with early-onset cerebral vein thrombosis 121
Epatopatia e coagulazione 121
Denaturing HPLC procedure for factor IX gene scanning 120
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 120
Arterial Thrombosis in Cancer Patients: An Update 114
Performance of Ca-based sorbents for calcium looping processes: role of steam 113
Fluidized bed co-combustion of hydrothermally treated paper sludge with two coals of different rank 113
Fragmentation of biomass-templated CaO-based pellets 109
Non-O blood group as a risk factor for cerebral vein thrombosis 108
Arthropathy in patients with moderate hemophilia A: A systematic review of the literature 108
Limestone attrition during fluidized bed calcium looping cycles for CO2 capture 107
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 107
Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis 105
Cost of care of haemophilia with inhibitors. 100
Acquired Hemophilia: An Overview on Diagnosis and Treatment 97
Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. 96
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 96
Management of ischemic heart disease in hemophiliac patients: new challenges from a case report and review of the literature 95
A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors? 94
Oral anticoagulant drugs and the risk of osteoporosis: New anticoagulants better than old? 92
First Diagnosis of Hemophilia B in a Nonagenarian 89
Managing haemorragic and thromboembolic risk in patients with acquired haemophilia 87
Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors. 86
Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues. 79
Prenatal diagnosis of haemophilia: our experience of 44 cases. 73
Longer-acting factor VIII to overcome limitations in haemophilia management the PEGylated liposomes formulation issue. 70
Bleeding and thrombosis in multiple myeloma and related plasma cell disorders 69
Homocysteine and arterial thrombosis: Challenge and opportunity. 68
Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. 66
The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology 65
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues 61
Air pollution, vascular disease and thrombosis: Linking clinical data and pathogenic mechanisms 58
Totale 5.256
Categoria #
all - tutte 18.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.415


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022229 0 0 0 0 0 4 1 5 51 30 42 96
2022/2023301 39 9 8 19 32 30 0 50 32 58 22 2
2023/2024198 8 48 27 24 7 6 2 17 2 1 38 18
2024/20251.393 68 90 4 9 18 138 137 90 81 115 531 112
2025/20262.496 288 186 240 252 506 98 305 106 259 152 54 50
2026/2027300 14 84 95 107 0 0 0 0 0 0 0 0
Totale 5.256